GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kolon TissueGene Inc (XKRX:950160) » Definitions » Future Policy Benefits

Kolon TissueGene (XKRX:950160) Future Policy Benefits


View and export this data going back to 2017. Start your Free Trial

What is Kolon TissueGene Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Kolon TissueGene Business Description

Traded in Other Exchanges
N/A
Address
9713 Key West Avenue, Suite 300, Rockville, MD, USA, 20850
Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.